Next Article in Journal
Breaking the Barrier: SARS-CoV-2 Infections in Wild and Companion Animals and Their Implications for Public Health
Next Article in Special Issue
Role of miRNA in Highly Pathogenic H5 Avian Influenza Virus Infection: An Emphasis on Cellular and Chicken Models
Previous Article in Journal
Hepatitis B Virus Genotypes and Subgenotypes Circulating in Infected Residents in a Country with High Vaccination Rate
Previous Article in Special Issue
Natural Infection with Highly Pathogenic Avian Influenza A/H5N1 Virus in Pet Ferrets
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Viruses
Volume 16
Issue 6
10.3390/v16060955
viruses-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Spontaneous Lethal Outbreak of Influenza A Virus Infection in Vaccinated Sows on Two Farms Suggesting the Occurrence of Vaccine-Associated Enhanced Respiratory Disease with Eosinophilic Lung Pathology

by
Wencke Reineking
1,
Isabel Hennig-Pauka
2,
Ludger Schröder
3,
Ulf Höner
4,
Elena Schreiber
2,
Lukas Geiping
2,
Simon Lassnig
5,6,
Marta C. Bonilla
5,6,
Marion Hewicker-Trautwein
1 and
Nicole de Buhr
5,6,*
1
Department of Pathology, University of Veterinary Medicine Hannover, 30559 Hannover, Germany
2
Field Station for Epidemiology, University of Veterinary Medicine Hannover, 49456 Bakum, Germany
3
Tierärztliche Praxis Peheim, 49696 Peheim, Germany
4
Tierärztliche Praxis in Schöppingen, 48624 Schöppingen, Germany
5
Institute of Biochemistry, University of Veterinary Medicine Hannover, 30559 Hannover, Germany
6
Research Center for Emerging Infections and Zoonoses (RIZ), University of Veterinary Medicine Hannover, 30559 Hannover, Germany
*
Author to whom correspondence should be addressed.
Viruses 2024, 16(6), 955; https://doi.org/10.3390/v16060955
Submission received: 3 June 2024 / Revised: 11 June 2024 / Accepted: 11 June 2024 / Published: 13 June 2024
(This article belongs to the Special Issue Advances in Animal Influenza Virus Research: Third Edition)
Browse Figures
Review Reports Versions Notes

Abstract

:
Influenza A virus (IAV) infections in swine are usually subclinical, but they can reach high morbidity rates. The mortality rate is normally low. In this study, six vaccinated, spontaneously deceased sows revealed IAV infection and enhanced neutrophilic bronchopneumonia with unexpectedly large numbers of infiltrating eosinophils. The purpose of this study was to characterize these lung lesions with special emphasis on the phenotypes of inflammatory cells, the presence of eosinophilic peroxidase (EPO), and neutrophil extracellular traps (NETs). The number of Sirius red-stained eosinophils was significantly higher in the lungs of IAV-infected sows compared to healthy pigs, indicating a migration of eosinophils from blood vessels into the lung tissue stimulated by IAV infection. The detection of intra- and extracellular EPO in the lungs suggests its contribution to pulmonary damage. The presence of CD3+ T lymphocytes, CD20+ B lymphocytes, and Iba-1+ macrophages indicates the involvement of cell-mediated immune responses in disease progression. Furthermore, high numbers of myeloperoxidase-positive cells were detected. However, DNA-histone-1 complexes were reduced in IAV-infected sows, leading to the hypothesis that NETs are not formed in the IAV-infected sows. In conclusion, our findings in the lungs of IAV-infected vaccinated sows suggest the presence of so far unreported field cases of vaccine-associated enhanced respiratory disease.

1. Introduction

Influenza A virus (IAV) infections are endemic in herds of domestic swine worldwide [1,2,3,4]. Genetic reassortment of human and/or avian, and/or swine IAVs occurs very frequently and is responsible for the epidemiological situation of influenza in pigs [4].
According to phylogenetic and epidemiological investigations, four main swine IAV subtypes circulate in European swine populations [5,6,7]. The avian-derived virus referred to as H1avN1av was introduced from waterfowl to pigs [2]. Swine H3N2 resulted from the reassortment of porcine H1avN1 with a human seasonal H3N2 [7]. The human-like H1N2 (H1huN2) developed from the reassortment of porcine H3N2 with human-seasonal H1N1. In 2009, the human pandemic IAV (H1N1/2009 H1N1pdm), which was of porcine origin, emerged [5,6]. This virus became endemic and, since 2009, several reassortants including H1pdm subtypes have been detected among pigs in Europe [2,6].
Swine influenza viruses (SIVs) are a major cause of acute respiratory disease of high morbidity in piglets, fattening pigs, and sows [1,4] and, in spite of vaccination, infections with SIVs occur worldwide [2,3]. Clinical signs in typical outbreaks of influenza in pigs include fever, lethargy, dyspnea, nasal discharge, cough, and inappetence [4]. Outbreaks of IAV infections of swine in the field usually are subclinical or mild and can reach a high morbidity rate, but are in general, except from rare reports, of less than 1% mortality [4,8,9,10].
The virulence and pathogenicity of IAV in pigs, however, can be quite variable [4,8,9]. Several reports describe that the inoculation of non-vaccinated pigs with different influenza viruses of porcine, avian, or human origin resulted in non-fatal respiratory disease and lung lesions of varying degrees from only mild to moderate or even severe [11,12,13,14].
Although the severity and extent of lung lesions occurring in pigs after spontaneous or experimental infections with different IAV strains and reassortants can vary considerably, their histopathological features are essentially the same [9,15]. Pneumonic lesions in IAV-infected pigs are mainly characterized by necrotizing bronchitis and bronchiolitis with the presence of desquamated epithelial cells, neutrophils, and macrophages in the lumina of airways and alveoli, and accumulations of lymphocytes around bronchi, bronchioles, and adjacent blood vessels [4,9]. In formalin-fixed paraffin-embedded lung tissue from IAV-infected pigs, viral antigen or RNA can be detected immunohistochemically with mono- and polyclonal antibodies against type A nucleoprotein or in situ hybridization, respectively [16,17].
Vaccination with whole inactivated virus (WIV) with adjuvant is an important tool to control IAV infections in pigs. Application of WIV vaccines in pigs induces the production of neutralizing antibodies to viral hemagglutinin (HA) [18]. The efficacy of such vaccines depends on the homology between the HA of the IAV vaccine and the infection strain, and it is known that vaccine efficacy is reduced against heterologous IAV strains [18,19].
Experiments in pigs have shown that after vaccination with an oil-in-water emulsion adjuvanted WIV and subsequent challenges with heterologous, antigenically mismatched swine IAV strains of the same IAV subtype, vaccine-associated enhanced respiratory disease (VAERD) can occur [20,21]. The pathogenic mechanisms underlying experimentally induced VAERD in pigs are not completely understood. It is discussed that antibody-dependent cellular cytotoxicity (ADCC) involving cross-reactive non-neutralizing antibodies with complement activation and T cell responses leading to the production of pro-inflammatory cytokines likely plays a role in neutrophil recruitment to the lungs and the development of pulmonary tissue damage [20,22,23].
Depending on the stimulus, neutrophils can undergo different mechanisms after infiltrating lung tissue during infections. These include the release of neutrophil extracellular traps (NETs) [24]. During NET formation, neutrophils release a DNA backbone with attached granule proteins like myeloperoxidase (MPO), histones, and antimicrobial peptides [25,26]. NET formation was detected in the lungs of pigs during bacterial infections with Actinobacillus pleuropneumoniae (APP) [27] and Streptococcus suis [28] and during IAV infection [29]. NETs can be beneficial for the host as they bind and disarm pathogens. However, if they are not sufficiently regulated, an overproduction of NETs can cause detrimental effects to the host [30]. In addition to neutrophils, other cells like eosinophils are described to release extracellular traps (ETs), but to a lesser extent [31].
In humans and animal models, the occurrence of VAERD is associated with the accumulation of eosinophils in the lungs, also known as VAERD with eosinophilic lung pathology. It has been reported for vaccines and vaccine candidates such as respiratory syncytial virus (RSV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [32].
In this study, we report spontaneous sudden deaths in six vaccinated, IAV-infected sows with necrotizing bronchopneumonia characterized by the infiltration of lung tissue not only with neutrophils but also with high numbers of eosinophils, suggesting the presence of so-far-unreported field cases of IAV-associated VAERD in pigs. The aim of this investigation was to characterize the lung lesions in these six sows with special emphasis on the participation of eosinophils and mononuclear inflammatory cells.

2. Materials and Methods

2.1. Animals

Six sows from two different sow farms in northwest Germany were sent to the Field Station for Epidemiology of the University of Veterinary Medicine Hannover in Bakum for diagnostic necropsy due to sudden death. Farm A was a 3000-sow farm with a separated gilt acclimatization unit and areas for breeding and gestating sows. Sows were transported to external farrowing sites. Every 4 weeks, 120 gilts at the age of 14 weeks were purchased from a gilt rearing farm, where gilts had been vaccinated twice in weeks 10 and 14 of life with two commercial WIV vaccines against different swine influenza virus A subtypes (vaccine A (Respiporc FLU3, Ceva, Düsseldorf, Germany): H3N2, H1N1, H1N2, and carbomer as adjuvant; vaccine B (Respiporc FLUpan H1N1, Ceva, Düsseldorf, Germany): H1N1pdm09 and carbomer as adjuvant). After the acclimatization period of three months, gilts were vaccinated with vaccine B at the age of six months and four weeks later, after transfer to the breeding area, with vaccine A. In addition, gilts were vaccinated against porcine parvovirus, erysipelas, porcine circovirus 2 (PCV2), and Mycoplasma (M.) hyopneumoniae at the age of six months and again four weeks later against parvovirus and erysipelas and once against the Porcine Respiratory and Reproductive Syndrome Virus (PRRSV) with a modified live-virus vaccine (PRRSV-1 MLV vaccine). Some days after the second vaccination against swine influenza at the age of 210 days, seven out of 120 gilts died suddenly without showing any clinical signs. Three of these sows were submitted for necropsy to the Field Station for Epidemiology. Within the whole group, individual animals showed slight coughing.
Farm B was a closed farm with 490 sows farrowing in 5-week intervals. Sows were routinely vaccinated against PRRSV using a PRRSV-1 MLV every three months. Three weeks before farrowing, all sows were vaccinated against pandemic influenza virus using vaccine B (H1N1pdm09 and carbomer as adjuvant) as well as an autogenous killed vaccine containing Escherichia coli, Clostridium perfringens type A, and Rotavirus A. Within a period of four weeks, several sows had shown fever, and eight sows died. Three pregnant sows died one week after PRRSV-1 MLV and influenza virus vaccination and were submitted for necropsy to the Field Station for Epidemiology. The last influenza virus vaccination had been six months previous.

2.2. Post-Mortem Examination

Necropsy was performed according to routine diagnostic procedures in the laboratory accredited by the national accreditation body of the Federal Republic of Germany (DIN EN ISO 17025.2017). After assessment of the pig’s carcass, the head was separated from the body for later opening of the cranial cavity and sampling of tonsillar tissue, and the joints were opened and examined. After opening the pleural cavity, the lungs were removed, assessed, and sampled. The right main bronchus was clipped, so that one lung could be rinsed with 400 mL phosphate-buffered saline to gain bronchoalveolar lavage fluid for further examinations. Lung tissue samples including a main bronchus and another one without a main bronchus were harvested from the non-rinsed left lung (cranial and main lung lobe) for bacteriological and molecular biological diagnostics (PCR). In addition, neighboring tissue parts were sampled in 10% neutral buffered formalin (NBF) and were sent to the Department of Pathology, University of Veterinary Medicine Hannover, for histological examination. Routinely, altered lung tissue is sampled with high priority, but in the examined animals, no obvious lung alterations were seen. Subsequently, abdominal organs, including the examination of the gut mucosal surface at various locations, were examined after the opening of the abdominal cavity.

2.3. Bacteriological Examination of Lung Tissue

Lung tissues, sampled for bacteriological examination, were processed immediately after necropsy. Samples for PCR diagnostic were either frozen until testing or also immediately analyzed.
The routine standard operating procedure for the diagnostic of bacterial pathogens for samples from the respiratory tract is based on knowledge of clinical veterinary microbiology. Tissue samples were plated on four conventional agar plates, including chocolate blood agar containing nicotinamide adenine dinucleotide (NAD, Blood Agar No. 2, Becton, Dickinson and company, Sparks, USA) for the culture of Pasteurellaceae and Alcaligenaceae, CNA blood agar (Becton, Dickinson and Company, Sparks, NV, USA) containing nalidixic acid and polymyxin E for the selective culture of Staphylococcus spp. and Streptococcus spp., Columbia agar with 5% sheep blood (Becton, Dickinson and Company, Sparks, NV, USA), and Gassner agar (OXOID, Hampshire, UK). After culturing for 24 h at 37 °C under atmospheric conditions or in an 8% CO2 atmosphere (chocolate blood agar), bacterial growth was recorded. A second inspection of agar plates was performed after a further growth period of 24 h. Bacterial colonies of interest were subcultured for characterization by their biochemical characteristics.

2.4. Molecular Biological Diagnostic of Viral Pathogens

For a PCR diagnostic, RNA was extracted from lung tissue (2 × 25 mg) using a commercially available RNA extraction kit (RNeasy Blood and Tissue Kit, Qiagen GmbH, Hilden, Germany). A pathogen-specific protocol with respect to the master mix and temperature protocol was used. The master mix and the temperature protocol differed between the different pathogens. The master mix protocols and cycling conditions for PRRSV and swine influenza A virus were conducted as previously described [33,34].
The PCR diagnostic of PRRSV-1 (EU) and -2 (US) as well as swine influenza A virus was based on commercial PCR diagnostic kits. The use of the PRRSV RT-PCR (EZ-PRRSVTM MPX 4.0 assay, Tetracore R, Rockville, MD, USA) allowed the differentiation of PRRSV-1 and -2 [33]. The utilized RT-PCR (EZ-Universal Flu A 2.0 RT-PCR, Tetracore R, Rockville, MD, USA) allowed the detection of all known swine influenza subtypes [34].
Amplification was performed in a real-time cycler (Applied Biosystems 7500 Real Time PCR System, Thermo Fisher Scientific, Waltham, MA, USA).

2.5. Histopathology

Two tissue samples of the lungs of the six sows from cranial and main lung lobes were fixed in 10% NBF for at least 24 h. Thereafter, samples were trimmed, dehydrated, and embedded in paraffin wax according to routine protocols. Sections of 2–3 µm thickness were cut and stained with hematoxylin–eosin (H&E) as well as Sirius red according to routine protocols [35] and subsequently evaluated by two certified, experienced pathologists (MHT, WR).
In addition, paraffin blocks with NBF-fixed lung tissue from pigs originating from eight different farms affected by either IAV (Table 1, farm C-G) or porcine pleuropneumonia (APP, Table 1, farm H-J) in various age groups were selected from the archives of Department of Pathology and the Field Station for Epidemiology (Table 1). In cases of swine influenza, infection with IAV had been proven with the PCR of native lung tissue. For all APP cases, infection with Actinobacillus pleuropneumoniae had been detected by bacteriological culture of native tissue.
Furthermore, paraffin blocks with normal lung tissue fixed in NBF were selected from six healthy control pigs of previous animal experiments (Table 1, farm RIZ). These samples were collected from the left Lobus cranialis. This animal experiment was approved by the authorities in the committee on animal experiments of the Lower Saxonian State Office for Consumer Protection and Food Safety (Niedersächsisches Landesamt für Verbraucherschutz und Lebensmittelsicherheit (LAVES), Lower Saxony, Germany, registration number 33.8-42502-04-18/2879) [36]. No animal was euthanized for the purpose of this study.
For the semiquantitative evaluation of histopathological lung lesions, H&E stained slides were analyzed according to a previous report about experimentally induced VAERD in pigs [37] (Appendix A Table A1). Scores were based on the most severe lesion within all lung sections of one animal for necrosis and regeneration of bronchi and bronchioles, peribronchiolar and perivascular cuffing, as well as vascular lesions, such as endothelialitis or perivascular edema, independent from the number and/or area of affected tissue. The percentage of affected tissue over all sections of pulmonary tissue was evaluated and diagnosed with a 4-tier scheme for bronchitis, edema, and hemorrhage (Appendix A Table A1).

2.5.1. Quantitative Evaluation of Peribronchial and -Bronchiolar Eosinophils in Normal and Inflamed Lungs

Sirius red-stained lung sections were scanned with an Olympus VS200 (Olympus Deutschland GmbH, Hamburg, Germany) with transmitted light at 20× magnification and subsequently analyzed with QuPathsoftware version 0.4.3 (evaluated area) and ImageJ version 1.5.4 (number of eosinophils). Numbers of eosinophils per counted area were normalized to the number of eosinophils per mm2 (EGC/mm2). Data sets were compared statistically with normal porcine lung tissue as well as the porcine pleuropneumonia cases with the GraphPad Prism version 10.0.2 (232) (GraphPad Software, San Diego, CA, USA).

2.5.2. Immunohistochemistry

Porcine lung samples were deparaffinized and rehydrated in a decreasing alcohol series. Thereafter, either enzymatic or heat-induced antigen retrieval was performed. Slides were blocked with normal goat serum before the application of primary antibodies. Primary antibodies (eosinophilic peroxidase (EPO), influenza A nucleoprotein (IAV NP), CD3, CD20, Iba-1) were incubated overnight at 4 °C and subsequently labeled with appropriate biotinylated goat anti-mouse or goat anti-rabbit preabsorbed secondary antibodies (Abcam, Berlin, Germany) for 45 min at room temperature. Similar IgG concentrations of rabbit or mouse sera were used as negative control stainings. Porcine lymph nodes served as positive controls for CD3, CD20, EPO, and Iba-1. An influenza-infected pig lung (animal no. F2) was used as a positive control for IAV NP. Tissue pretreatment and primary antibody dilutions are listed in Table 2. Immunolabelling was visualized with the VectorStain peroxidase kit and 3, 3′ diaminobenzidine as chromogen according to routine protocols [38].

2.5.3. Evaluation of Extracellular Traps (ETs) in Affected Lungs of Sows

The paraffin-embedded lung tissue sections (2–3 µm thick sections) were analyzed in batches of 10 lung slices at the same time. Sections were stained for immunofluorescence analysis as described previously [39]. Briefly, ETs were stained using the following as primary antibodies: a mouse anti-DNA/histone 1 (IgG2a; MAB3864; Sigma Aldrich, Millipore 1.5 mg/mL diluted 1:273, Billerica, MA, USA) and a rabbit anti-human myeloperoxidase (IgG; A039829-2 Agilent, Santa Clara, CA, USA, 4 mg/mL, 1:364). A respective isotype control was included in each staining batch: murine IgG2a (from murine myeloma, M5409-1 mg conc. 0.2 mg/mL, 1:36.4 Sigma Aldrich, Munich, Germany) and rabbit IgG (from rabbit serum, Sigma Aldrich, Munich, Germany, I5006, 1.16 mg/mL, 1:105.5). All antibodies were incubated overnight at 4 °C.
As secondary antibodies, goat anti-mouse Alexa 488Plus (# A32723, 2 mg/mL, Invitrogen, Carlsbad, CA, USA) and goat anti-rabbit Alexa 568 (# A11011, 2 mg/mL, Invitrogen, Carlsbad, CA, USA, 2 mg, Waltham, MA, USA), both diluted 1:500 in blocking buffer, were used. All samples were processed using the TrueVIEW autofluorescence quenching kit (# SP-8400-15, Vector Laboratories, Newark, CA, USA) following the manufacturer’s instructions and counterstained using Hoechst 33342 (1:1000, stock 50 mg/mL, Sigma Aldrich, Munich, Germany).
The samples were imaged using a Leica TCS SP5 AOBS confocal inverted-base fluorescence microscope with an HCX PL APO ×40 0.75–1.25 oil immersion objective. The settings for each batch were adjusted to their respective isotype controls. Per lung slice, 10 images were randomly taken without overlap. The raw integrated density was measured using ImageJ software (ver. 1.51) for the three different color channels (blue = DNA [counterstaining], green = DNA/histone-1-complexes, and red = MPO). The raw integrated density of both antibody signals was then set in relation to the raw integrated density of the counterstaining.
Data were analyzed using Excel 2016 (Microsoft) and GraphPad Prism 10.0.2 (GraphPad Software, San Diego, CA, USA). Data are presented with mean ± SD as described in the figure legends. The differences between groups were analyzed as described in the figure legends (* p < 0.05, ** p < 0.01, *** p < 0.001).

3. Results

3.1. Gross and Histopathological Findings

At necropsy, the lungs of the six sows showed no retraction and alveolar edema. Due to extended interlobar septae, interstitial pneumonia was suspected.
The three IAV-positive pigs from the archive of the Department of Pathology exhibited poorly retracted and hyperemic lungs as well as hyperplastic and edematous pulmonary lymph nodes.
APP lungs showed poor retraction as well as multifocal to coalescing areas of hyperemia, atelectasis, and consolidation. The visceral pleura was multifocally attached to the pleura of the thoracic cavity. Pulmonary lymph nodes were enlarged and edematous.
A histological examination of the lung tissue of all six sows (Appendix A Table A2) revealed the presence of necrotic airway epithelium with bronchitis and bronchiolitis associated with the infiltration of numerous neutrophilic and eosinophilic granulocytes. In the lungs of all six sows, there was mild broncho-interstitial mononuclear pneumonia. Furthermore, peribronchial lymphocytic cuffing was found in all six sows, and the majority of animals showed mild to severe perivascular infiltrates of mononuclear cells (Figure 1). Semiquantitative scoring revealed that all lesions varied from mild to severe between the lung tissue samples of the individual animals (Appendix A Table A2).
The six IAV-infected pigs of younger age groups (Table 1, farm C-G) showed comparable but less severe changes in lung parenchyma. Vascular changes were especially less severe in these animals.
The six APP pigs (Table 1, farm H-J) with pleuropneumonia showed different stages of the disease. In some areas, hyperemia and proteinaceous fluid admixed with some neutrophils were the most prominent features, while in other areas, fibrinous exudate and neutrophils were accentuated. In addition, areas with complete loss of normal tissue architecture due to coagulative necrosis were demarcated by moderate to high numbers of viable and degenerated neutrophils. Throughout the sections, varying numbers of oat cells were present.
In the lung tissue of six healthy control pigs, except from multifocal to diffuse atelectasis and/or emphysema, no histological abnormalities were found.

3.2. Quantification of Neutrophil Extracellular Traps (NETs) in Lung Tissue Sections

Using confocal immunofluorescence microscopy, NET-formation was analyzed in lung tissue sections with quantification of DNA-histone-1 complexes and MPO. The immunofluorescence intensity for both markers was calculated in relation to the staining of DNA (blue), as this reflects the number of nuclei. The values for DNA-histone-1-complexes were significantly reduced in IAV-infected pigs of younger age groups and IAV-infected sows, whereas a significantly increased intensity of the MPO signal was detected in the IAV-infected sows (Figure 2).

3.3. Quantification of Eosinophilic Granulocytes in Sirius Red-Stained Lung Tissue Sections

Infiltration of eosinophils in all diseased animal groups was accentuated around the conductive airways and vasculature (Figure 3), while low numbers of eosinophils were distributed randomly throughout the parenchyma in all animals of the unaffected control group. In all pigs of the diseased groups, varying numbers of eosinophils were detected in the alveolar septa, with the highest numbers in the IAV-infected sows. In one sow (animal no. B3), Sirius red staining was not evaluable because of repeatedly reduced staining quality and intensity.
Quantification and statistical evaluation of the number of eosinophils in the lung tissue of the four groups of examined pigs revealed that their number was significantly higher in the lungs of the six IAV-infected sows than in pigs with pleuropneumonia (p = 0.02) and in healthy control pigs (p = 0.0068) (Figure 4, Appendix A Table A3). The tissue sections of six sows yielded a mean count of 48.74 cells/mm2 (range: 12.2–126.5), while in the six IAV-infected pigs of younger age groups, a mean count of 12.28 cells/mm2 (range: 2.7–30.3) was detected. The lowest mean values were detected in APP pigs with 7.2 cells/mm2 (range: 0.15–26.3) and the healthy controls with 4.78 cells/mm2 (range: 1.8–12.2).

3.4. Results of Immunohistochemistry for EPO

EPO distribution resembled the staining pattern of Sirius red-positive cells. In addition, the deposition of EPO was detected in the perivascular and/or peribronchiolar areas of all four groups (Appendix A Figure A1).

3.5. Phenotyping of Pulmonary Inflammatory Cell Infiltrate

All animals of IAV, APP, and healthy control groups showed mild to moderate infiltration of CD3+ T lymphocytes and lower numbers of CD20+ B lymphocytes. In the six sows, a slight increase in T and B lymphocytes was seen (Appendix A Figure A2A,B).
Moderate to severe numbers of Iba-1+ macrophages were detected in all diseased animals, but slightly less in the healthy controls (Appendix A Figure A2C, Appendix A Table A4 and Table A5).

3.6. Immunohistochemical Detection of IAV NP Antigen in Lung Tissue

IAV nucleoprotein antigen was only detected in three ‘IAV pigs’ (F1, F2, G1) and was mainly found within the nuclei of low numbers of bronchial and bronchiolar epithelial cells, especially within affected bronchi and bronchioles. Occasionally, positive nuclei were also present in the peribronchial cuffs. No animal of the ‘IAV sows’, APP, and healthy control groups showed IAV positivity (Appendix A Figure A2D).

3.7. Virological and Bacteriological Results

The selection of further diagnostic procedures in animals sent for routine diagnostics was dependent on the anamnestic report and organ alterations detected during necropsy. Bacterial pathogens were not found in five sows. Only from the lung tissue of one sow (pig B2), β-hemolytic streptococci were cultured in low amounts. The lung tissue of all sows was tested for PRRSV with negative results.
Due to the fact that PCV2 vaccination was performed on all farms and no typical organ alterations were present (e.g., swollen lymph nodes, wasting), only two gilts from farm A were tested for this pathogen. The subtyping of IAV from BALF or lung tissue was not performed in all sows from the same farm due to cost reasons. The success of subtyping from tissue samples depends on viral load and is not always successful. Diagnostic findings are summarized in Table 3.

4. Discussion

In this study, six sows from two different farms in northwest Germany had been submitted for necropsy because of sudden death. Histopathology revealed the presence of extended necrotizing bronchopneumonia. Using PCR and immunohistochemistry on lung tissue samples, IAV RNA was found in all six animals, but no intralesional IAV NP antigen was detected.
The clinical outcome of infections of swine with IAVs is not only affected by the immune status but also different factors such as age, infection pressure, climatic conditions, homing, and secondary infections with bacteria or other viruses [4]. Outbreaks of IAV infections in swine are usually of low mortality [4,8,9]. There are only a few reports about spontaneous outbreaks of fatal IAV infections with severe lung lesions in pigs in the field [10,40]. In the report of Ma et al. [10], 10% mortality in a herd of finishing pigs was due to a highly virulent triple reassortant H1N1 virus and was characterized as moderate, subacute to chronic bronchopneumonia, and from the lungs of dead animals, in addition to the influenza virus, PRRSV and bacteria, including Pasteurella multocida and Streptococcus suis, were isolated. In the study of Madec et al. (1989), a severe outbreak in sows was described from which the H1N1 virus was isolated and in which necropsy revealed extended lesions of bronchopneumonia and co-infection with Pasteurella multocida. In the present investigation, no co-infection of IAV with bacteria and/or additional viruses was detected in 7/8 sows. In one sow, β-hemolytic streptococci were detected in unaltered lung tissue.
Presumably, the sows examined in this study died from a breakthrough infection with IAV, although they had been vaccinated against IAV according to routine vaccination protocols with commercial WIV vaccines, i.e., a trivalent vaccine (H3N2, H1N1, H1N2), on one of the farms and with a monovalent vaccine (H1N1pdm09) on the other farm. The efficacy of WIV vaccines depends on the homology between the HA of the IAV vaccine and the infection strain. It is known that vaccine efficacy is reduced against heterologous IAV strains [18,19]. Furthermore, the application of such inactivated IAV vaccines cannot completely protect pigs against breakthrough infections because of genomic reassortment and the continuous genetic and antigenic diversity of IAV subtypes [18,41].
The histopathological character and the severity of the lung alterations found in the six sows of this investigation resemble findings described in reports about pigs with experimentally induced VAERD [20,21]. The histopathological features of bronchopneumonia occurring in pigs with experimentally induced VAERD are similar to those described for spontaneous porcine IAV infections, but lung lesions are of increased severity [9,20,21].
In contrast to reports about spontaneous IAV infections and experimentally induced VAERD in pigs, the most remarkable finding of this study was that not only neutrophils but also large numbers of Sirius red-stained eosinophils were present in the altered lung tissue of the IAV-infected sows. Sirius red-stained eosinophils were also present in the lungs of the healthy control pigs, but quantification and statistical evaluation clearly showed that their number was significantly higher in the lungs of the six IAV-infected sows.
In addition to blood eosinophils, tissue-resident eosinophils are regularly present in several tissues [42,43]. In humans and mice, they occur under steady-state conditions in the lungs, thymus, intestines, mammary glands, uterus, and adipose tissue [43,44,45].
Detailed information about the existence and number of tissue-resident eosinophils in the tissues of pigs is missing.
In this study, the lowest number of Sirius red-stained eosinophils was present in the histologically unremarkable lung tissue of the group of six healthy control pigs. Although the number of eosinophils varied between their lungs, which could be due to the low number of animals examined, our results suggest that they represent a physiological population of tissue-resident eosinophils as described for humans and mice [44,45].
As cells of the innate immune system, eosinophils are involved in immune homeostasis, immunity, and immune regulation [46], and their number increases in blood and tissues during specific immune responses and allergic diseases [45]. In response to infectious stimuli, including parasites, bacteria, fungi, and viruses, they can leave the bloodstream, traffic into inflammatory sites, and modulate the immune response [42,43].
In the literature, information about porcine eosinophils seems to be limited and mainly restricted to the characterization of the granule proteins of blood eosinophils [47] and studies on the release of their mediators during eosinophilia following the sensitization of pigs with Ascaris suum allergens [48]. In this study, there were no signs of parasitic infection as a possible cause for the presence of eosinophils in the lung tissue of the six sows or the lung tissue of the three different groups of control pigs. However, it cannot be excluded that the presence of eosinophils in the lung tissue of the six healthy control pigs may have been, at least in part, due to housing conditions, e.g., induced by contact with air pollutants such as allergens.
Our investigation revealed that the number of Sirius red-stained eosinophils was significantly higher in the lungs of all six cases of IAV-infected sows in comparison to the lungs of healthy control pigs. These results indicate that the majority of eosinophils in the lungs of the six IAV-infected sows represented cells that had migrated from blood vessels into the lung tissue stimulated by the influenza virus infection. Sirius red-stained eosinophils were also detected in the lungs of the control group of APP-infected pigs and the lungs of the control group of IAV-infected pigs. Possibly, the eosinophils found in the lung tissue of the two latter groups of pigs were attracted to the lung tissue due to infection with APP and IAV, respectively, although it cannot be excluded that the population of eosinophils in their lungs included tissue-resident eosinophils as well.
In reports about histopathological characteristics of bronchopneumonia in pigs with spontaneous or experimental IAV infection including VAERD [4,9,20,21], the participation of eosinophils as part of the inflammatory cell population was not described. In those experiments, VAERD was induced after vaccination with an oil-in-water emulsion adjuvanted WIV and subsequent challenge with a heterologous, antigenically mismatched swine IAV strain of the same IAV subtype [20,21]. The efficacy of WIV influenza vaccines depends on the homology of the IAV vaccine and the IAV infection strain and the effective production of neutralizing antibodies by the host [49]. In the last decades, novel IAV strains and cocirculating variants of the same subtype emerged in the European swine population [50]. Phylogenetic analyses revealed various hemagglutinin/neuraminidase combinations and more than 30 distinct swIAV genotypes as consequences of reassortments [6]. The IAV strains detected in the two farms were not genetically characterized for similarity with the used vaccine strains with respect to their hemagglutinin. One vaccine contained an avian-like H1N1 (A/sw/Haselunne/IDT2617/2001(H1N1) and a strain with human-like H1 (Bakum/1832/2000 (H1N2)). The vaccine, which was used on both farms, contained the pandemic strain A/Jena/VI5258/2009(H1N1)pdm09, in which the hemagglutinin was of swine virus origin [51]. Both IAV strains detected in the farms contained a hemagglutinin of avian origin (H1avN1, H1avN2), so a high heterogeneity between the vaccine and field strain can be assumed. It can be hypothesized that VAERD occurred in vaccinated pigs that were challenged at a later point in time by antigenically diverse IAVs. VAERD might have been mediated by nonprotective antibodies of low avidity in these animals.
The possible risk and occurrence of immunopathological reactions termed VAERD associated with vaccine candidates, which may be associated with eosinophilic lung pathology, has been reported in humans and animal models [32,52,53]. In the 1960s, VAERD occurred in children following vaccination with whole formalin-inactivated RSV vaccine and subsequent exposure to respiratory syncytial virus (RSV) [53,54]. In those cases, a severe inflammatory response occurred in the lungs, which was characterized not only by the presence of neutrophilic granulocytes, lymphocytes, and macrophages but also by numerous eosinophilic granulocytes [53,54]. VAERD associated with eosinophilic lung pathology is also a known problem in the research for vaccine development in human medicine, such as for infection with RSV and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in hamsters and mice [52,53,54,55].
Based on the results from those vaccination experiments, two immunopathological mechanisms involved in the development of VAERD have been identified. One of them involves antibodies without neutralizing activity leading to immune complex formation and deposition and the activation of complement and production of inflammatory cytokines, as demonstrated in the 1960s RSV vaccine trials in children [53]. A second pathway involves a biased T helper 2 (Th2)-like immune response resulting in inflammation with the production of a Th2-like cytokine spectrum with increased levels of interleukin-4 (IL-4), IL-5, and IL-13 leading to the development of VAERD with eosinophilic lung pathology [32,53,56].
The influx of eosinophils to the lungs was also described in sporadic reports about humans with spontaneous IAV infections, in which acute eosinophilic pneumonia associated with eosinophilia in peripheral blood or bronchoalveolar lavage fluid was diagnosed [57,58,59]. Furthermore, an influx of eosinophils into the lungs was demonstrated in a mouse model in which vaccinated animals, after challenges with mismatched influenza virus strains of the same subtypes, had influenza breakthrough infections [60,61].
The most remarkable result of this study was the presence of large numbers of eosinophils within the inflamed lung tissue of the six vaccinated sows that suddenly died from an IAV infection. The post-mortem results of the available tissue samples from the IAV-infected sows did not allow any conclusions regarding the possible mechanisms responsible for this unusual finding. However, we cannot exclude that the occurrence of spontaneous IAV-related VAERD associated with a Th2-biased immune response and production of Th2 cytokines was responsible for the attraction of eosinophils to the lungs of these animals.
So far, the occurrence of VAERD in pigs related to IAV was only described under experimental conditions [20,21,23,62], but not in pigs housed for commercial purposes [49]. In pigs with experimentally induced IAV-related VAERD, it is discussed that non-neutralizing antibodies, subsequent immune complex formation with complement activation as well as excessive expression of pro-inflammatory cytokines, i.e., TNF-α, IL-1β, IL-6, IL-8, and chemokines are involved in the development of enhanced pneumonia and neutrophilic infiltration of lungs [20,62,63].
The histopathological examination of the lung tissue of the IAV-infected pigs of this investigation showed that the inflammatory cell population in the lungs, in addition to neutrophils and eosinophils, also included mononuclear cells, i.e., lymphocytes and macrophages. Phenotypical characterization using immunohistochemistry revealed that CD3+ T lymphocytes, CD20+ B lymphocytes, and Iba-1+ macrophages were present in the inflamed lung tissue of the six sows of this study. A similar composition of inflammatory cells was described in VAERD in children vaccinated with the RSV vaccine [54]. These findings suggest that cell-mediated immune responses may contribute to enhanced disease in pigs with IAV-related VAERD, as already discussed by Gauger et al. (2012).
Using immunohistochemistry on lung tissue sections of the six examined sows, the presence of EPO was demonstrated in the cytoplasm of numerous eosinophils and also in extracellular tissue locations.
Eosinophils are known to contain a variety of mediators such as cytokines, chemokines, extracellular mitochondrial DNA traps (EETs), lipid mediators, and cytotoxic cationic granule proteins, e.g., major basic protein (MBP) and EPO [42,43,46,47]. However, in addition to detrimental effects, certain mediators of eosinophils can have beneficial effects, e.g., anti-infectious and anti-inflammatory effects [43,46]. In respiratory diseases induced by RSV and IAV, eosinophils participate in immune responses by interacting with different immune cells [64]. The results obtained in a combined mouse model of allergy and IAV infection suggest that eosinophils following piecemeal degranulation contribute to host cellular immunity by upregulating antigen presentation markers, modulating the function of T lymphocytes and dendritic cells, and promoting the reduction of virus replication [64,65]. Based on the findings of our investigation, it cannot be excluded that, in addition to mediators of neutrophils, the release of EPO and possibly other eosinophil-derived toxic mediators may have contributed to the lung tissue damage and inflammatory changes in the IAV-infected sows.
Research results about VAERD with eosinophilic lung pathology in SARS-CoV-2-vaccinated hamsters and RSV-vaccinated mice have shown that a Th2-biased immune response with secretion of Th2-associated cytokines is required for the influx of eosinophils into the lungs [52,66]. Regarding the pathogenic role of eosinophils, however, studies in RSV-vaccinated mice revealed that certain disease parameters were mediated by a Th2-biased immune response and distinct CD4 T cell subsets, but not by eosinophils alone [32,66]. On the other hand, in mice vaccinated with the influenza virus, in contrast to SARS-CoV-2-vaccinated hamsters, eosinophilic lung pathology was not associated with an overt Th2 cytokine pattern [60,61].
The association of eosinophils with lung lesions in pigs after spontaneous IAV infection in the field or experimentally induced IAV infection including VAERD has not been reported. The findings in the IAV-infected sows of this investigation suggest the occurrence of so far undescribed spontaneous cases of IAV-associated VAERD with eosinophilic lung pathology. Due to the retrospective character of this post-mortem study, the possible pathogenic role of the eosinophils found in the lungs of the IAV-infected sows regarding their contribution to the development of the lung tissue lesions and the possible roles of the eosinophils on the immune response of the infected sows remains unknown.
The examination of NETs showed an unexpected reduction of DNA-histone-1 complexes and a significantly increased amount of myeloperoxidase in the group of IAV-infected sows (Figure 2) compared to the control group. Whereas, in the IAV-infected piglets, the signal of DNA-histone-1 complexes was also significantly reduced, and MPO was not significantly increased. In an earlier study of APP-infected and non-infected pigs, we detected an increased signal of DNA-histone-1 complexes and neutrophil elastase in the lungs of the infected group and an increase in different NET markers in bronchoalveolar lavage fluid (BALF), indicating NET formation during the bacterial infection [27]. NETs can be induced by different stimuli, including pathogens like IAV [30,67]. Recently, we identified different NET markers in the BALF of IAV field-infected pigs and observed a positive correlation between NET markers and IAV viral load. Furthermore, neutrophils releasing vesicular NETs were found in the BALF of IAV-infected pigs [29]. However, there are no studies about NET formation in lung tissue during IAV in pigs, and it is not fully understood how NETs are induced by IAV [68]. The NET induction with IAV seems to be strain dependent [69]. The DNA-histone-1 complex is, together with MPO or neutrophil elastase, a NET marker if they are found colocalized and/or extracellularly. Nevertheless, the DNA-histone-1 complex is also staining cells that are not undergoing NET formation. Therefore, DNA-histone-1 complexes can be detected in healthy control animals. However, in the infected animals, we identified a reduced DNA-histone-1 complex signal, which can be due to tissue damage that is caused by NET components [70,71,72,73]. Therefore, a quantification analysis for NETs in histology sections based on the DNA-histone-1 complex could be a false negative. However, we identified single NET fibers in the histology sections (Figure 2). To understand the influence of NETs during VAERD, further analysis of example cells in BALF would be needed in future studies. In addition, it must be considered that eosinophils can release extracellular traps (ETs) as well [31]. After the first descriptions of eosinophil extracellular traps (EETs) [74], several further studies followed, describing EETs during infections with bacteria [75], fungi [76], and parasites [77]. Furthermore, EETs have been detected in an asthma mouse model with respiratory syncytial virus (RSV) infection [78] and in plastic bronchitis (PB) associated with IAV infection in humans [79]. Therefore, the observed NET fibers could be a product of the identified eosinophils as well.

5. Conclusions

In this study, necropsies on six vaccinated sows submitted because of sudden death from two different farms revealed an IAV infection with necrotizing bronchopneumonia characterized by the infiltration of lung tissue, in addition to neutrophils, with large numbers of eosinophils. Our findings suggest the presence of so far unreported field cases of IAV-associated VAERD in swine resulting from a breakthrough infection. Possibly, severe lung disease in vaccinated pigs in the field occurs more often but remains unnoticed in cases in which necropsy and histopathology are not performed. The histopathological findings in the lungs of the sows resemble descriptions of VAERD with eosinophilic lung pathology in humans and animal models associated with vaccine candidates for viruses, i.e., RSV and SARS-CoV-2. Immunohistochemistry revealed the presence of CD3+ T lymphocytes, CD20+ B lymphocytes, and Iba-1+ macrophages, suggesting that cell-mediated immune responses contributed to the enhanced inflammatory lung lesions. Our observations in these field cases of IAV-infected sows show that further research is needed regarding the efficacy of WIV IAV vaccines and the possible immunopathological mechanisms associated with IAV-associated VAERD in pigs, including the influence of ETs released by neutrophils and/or eosinophils.

Author Contributions

Conceptualization, I.H.-P., M.H.-T. and N.d.B.; Data curation, W.R., L.S., U.H., E.S., L.G., S.L. and M.C.B.; Formal analysis, W.R. and N.d.B.; Funding acquisition, N.d.B.; Investigation, W.R., L.S., U.H., E.S., L.G., S.L. and M.C.B.; Methodology, W.R., S.L., M.C.B. and N.d.B.; Supervision, M.H.-T. and N.d.B.; Visualization, W.R. and N.d.B.; Writing—original draft, W.R., I.H.-P., M.H.-T. and N.d.B.; Writing—review and editing, W.R., I.H.-P., L.S., U.H., E.S., L.G., S.L., M.C.B., M.H.-T. and N.d.B. All authors have read and agreed to the published version of the manuscript.

Funding

Simon Lassnig and parts of this project were supported by Zoonosenplattform with the BMBF/DLR project “IVIBAK”. We acknowledge financial support by the Open Access Publication Fund of the University of Veterinary Medicine Hannover, Foundation.

Institutional Review Board Statement

The animal study protocol was approved by the authorities in the committee on animal experiments of the Lower Saxonian State Office for Consumer Protection and Food Safety (Niedersächsisches Landesamt für Verbraucherschutz und Lebensmittelsicherheit (LAVES), Lower Saxonian, Germany under the registration number 33.8-42502-04-18/2879.

Informed Consent Statement

Not applicable.

Data Availability Statement

The authors confirm that the data supporting the findings of this study are available within the published article. Raw data were generated at the University of Veterinary Medicine Hannover, Foundation, Hannover, Germany. Derived data supporting the findings of this study are available from the corresponding author, N.d.B, after request.

Conflicts of Interest

The authors declare no conflicts of interest. The funders had no role in the design of this study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Appendix A

Table A1. Semiquantitative evaluation criteria of morphological pulmonary changes based on Gauger et al., 2014 [37].
Table A1. Semiquantitative evaluation criteria of morphological pulmonary changes based on Gauger et al., 2014 [37].
ScoreAutolysisNecrosis/Regeneration (Bronchi/Bronchioli)Extent of Bronchiolitis/BronchitisEdemaSeverity of Peribronchiolar CuffingSeverity of Perivascular Infiltrates
evaluated parameters median changes of epithelium (% of circumference)affection of airwaysseverity and distributionthickness of cuffing, independent from no. of affected airwaysthickness of cuffing, independent from no. of affected vessels
0nono changesno changesnonenonenone
1mild≤25%≤25%mild focal≤5 cell layers1–2 cell layers
2moderate26–50%26–50%moderate, locally extensive OR
mild to moderate, multifocal		6–10 cell layers3–5 cell layers
3severe51–75%51–75%severe, diffuse>10 cell layers>5 cell layers
4 ≥75%≥75%
Table A2. Semiquantitative evaluation of morphological pulmonary changes. NE, not evaluable.
Table A2. Semiquantitative evaluation of morphological pulmonary changes. NE, not evaluable.
FarmAnimal NoAutolysisNecrosis (Bronchi/Bronchioli)Bronchitis/BronchiolitisEpithelial RegenerationPeribronchiolar CuffingAlveolar EdemaAlveolar HemorrhageType II HyperplasiaPerivascular InfiltratesVascular Lesions
A11140112110
23440332000
31430322030
B12020133020
22220133020
31310222030
C11230111011
D10000111100
E10000020000
F12231320100
20111121100
G10241300131
H12NE40031000
21341321111
31330310101
41241112121
I11241110111
J11131212111
RIZ10000000000
20000000000
30000000000
40000000000
50000000000
60000010000
Table A3. Quantitative evaluation of Sirius red-positive cells in examined lung tissue.
Table A3. Quantitative evaluation of Sirius red-positive cells in examined lung tissue.
FarmAnimal No.Total SR+ CountTotal Area (mm2)SR+/Area (1/mm2)
A110676128.6982.96
216745132.41126.46
3291692.1631.64
B15571222.4125.05
21649134.7012.24
3Not evaluable
C11325116.3511.39
D1421155.072.71
E1679159.844.25
F14879161.0230.30
21169167.576.98
G12823156.3818.05
H1200145.141.38
254361.370.15
31677392.434.27
4260899.3226.26
I1723249.962.89
J11142138.118.27
RIZ1407146.152.78
212065.571.83
3307159.751.92
422199.302.23
53127255.6812.23
673495.727.67
Viruses 16 00955 g0a1
Figure A1. Detection of eosinophilic peroxidase (EPO) in porcine lung tissue. EPO was detected intracellularly within eosinophils in areas of high eosinophilic count (arrows). In addition, a perivascular and/or peribronchiolar extracellular immunolabeling for EPO was detected in all four groups. (A): IAV-infected sows; (B): younger IAV-infected pigs; (C): APP-infected pigs; (D): healthy control pigs. Indirect immunohistochemistry with 3,3′-diaminobenzidine as chromogen. Bars: 500 μm.
Figure A1. Detection of eosinophilic peroxidase (EPO) in porcine lung tissue. EPO was detected intracellularly within eosinophils in areas of high eosinophilic count (arrows). In addition, a perivascular and/or peribronchiolar extracellular immunolabeling for EPO was detected in all four groups. (A): IAV-infected sows; (B): younger IAV-infected pigs; (C): APP-infected pigs; (D): healthy control pigs. Indirect immunohistochemistry with 3,3′-diaminobenzidine as chromogen. Bars: 500 μm.
Viruses 16 00955 g0a1
Viruses 16 00955 g0a2
Figure A2. Semiquantitative analysis of mononuclear cells and influenza A nucleoprotein. (A): CD3-positive T lymphocytes were present in moderate to high numbers within all examined sections. A slight increase in T lymphocytes was noted in the IAV-infected sows (VAERD). (B): Low to moderate numbers of CD20-positive B lymphocytes were detected accentuated in the BALT areas within all groups. (C): Iba-1-positive cells were increased in all disease groups compared to the healthy controls. No differences were noted between the different disease groups. (D): Scattered immunoreactivity for influenza A nucleoprotein (IAV score) was detected in three fattening pigs. (A–D): Min-to-max Box-and-Whisker-plot. APP, Actinobacillus pleuropneumoniae; IAV, Influenza A infected young pigs; VAERD, IAV-infected sows.
Figure A2. Semiquantitative analysis of mononuclear cells and influenza A nucleoprotein. (A): CD3-positive T lymphocytes were present in moderate to high numbers within all examined sections. A slight increase in T lymphocytes was noted in the IAV-infected sows (VAERD). (B): Low to moderate numbers of CD20-positive B lymphocytes were detected accentuated in the BALT areas within all groups. (C): Iba-1-positive cells were increased in all disease groups compared to the healthy controls. No differences were noted between the different disease groups. (D): Scattered immunoreactivity for influenza A nucleoprotein (IAV score) was detected in three fattening pigs. (A–D): Min-to-max Box-and-Whisker-plot. APP, Actinobacillus pleuropneumoniae; IAV, Influenza A infected young pigs; VAERD, IAV-infected sows.
Viruses 16 00955 g0a2
Table A4. Semiquantitative evaluation criteria for immunohistological staining.
Table A4. Semiquantitative evaluation criteria for immunohistological staining.
IHC ScoreImmunoreactive Cells
0none
1rare
2low numbers
3moderate numbers
4high numbers
Table A5. Semiquantitative evaluation of immunohistological staining for mononuclear inflammatory cells and influenza A nucleoprotein (IAV NP).
Table A5. Semiquantitative evaluation of immunohistological staining for mononuclear inflammatory cells and influenza A nucleoprotein (IAV NP).
FarmAnimal No.IAVCD3CD20Iba-1
A10334
20214
30424
B10423
20322
30434
C10214
D10224
E10214
F13423
21323
G11334
H10223
20234
30324
40224
I10324
J10323
RIZ10223
20223
30222
40323
50323
60322

References

  1. Beaudoin, A.; Johnson, S.; Davies, P.; Bender, J.; Gramer, M. Characterization of influenza a outbreaks in Minnesota swine herds and measures taken to reduce the risk of zoonotic transmission. Zoonoses Public Health 2012, 59, 96–106. [Google Scholar] [CrossRef] [PubMed]
  2. Li, Y.; Robertson, I. The epidemiology of swine influenza. Anim. Dis. 2021, 1, 21. [Google Scholar] [CrossRef] [PubMed]
  3. Rose, N.; Hervé, S.; Eveno, E.; Barbier, N.; Eono, F.; Dorenlor, V.; Andraud, M.; Camsusou, C.; Madec, F.; Simon, G. Dynamics of influenza A virus infections in permanently infected pig farms: Evidence of recurrent infections, circulation of several swine influenza viruses and reassortment events. Vet. Res. 2013, 44, 72. [Google Scholar] [CrossRef] [PubMed]
  4. van Reeth, K.; Vincent, A.L. Diseases of swine—Influenza viruses. In Disease of Swine, 11th ed.; Zimmermann, J.J., Karriker, L.A., Ramirez, A., Schwartz, K.J., Stevenson, G.W., Zhang, J., Eds.; John Wiley & Sons, Ltd.: Hoboken, NJ, USA, 2019; pp. 576–593. ISBN 978-1-119-35085-9. [Google Scholar]
  5. Harder, T.C.; Grosse Beilage, E.; Lange, E.; Meiners, C.; Döhring, S.; Pesch, S.; Noé, T.; Grund, C.; Beer, M.; Starick, E. Expanded cocirculation of stable subtypes, emerging lineages, and new sporadic reassortants of porcine influenza viruses in swine populations in Northwest Germany. J. Virol. 2013, 87, 10460–10476. [Google Scholar] [CrossRef] [PubMed]
  6. Henritzi, D.; Petric, P.P.; Lewis, N.S.; Graaf, A.; Pessia, A.; Starick, E.; Breithaupt, A.; Strebelow, G.; Luttermann, C.; Parker, L.M.K.; et al. Surveillance of European Domestic Pig Populations Identifies an Emerging Reservoir of Potentially Zoonotic Swine Influenza A Viruses. Cell Host Microbe 2020, 28, 614–627.e6. [Google Scholar] [CrossRef] [PubMed]
  7. Simon, G.; Larsen, L.E.; Dürrwald, R.; Foni, E.; Harder, T.; Van Reeth, K.; Markowska-Daniel, I.; Reid, S.M.; Dan, A.; Maldonado, J.; et al. European surveillance network for influenza in pigs: Surveillance programs, diagnostic tools and Swine influenza virus subtypes identified in 14 European countries from 2010 to 2013. PLoS ONE 2014, 9, e115815. [Google Scholar] [CrossRef]
  8. Detmer, S.E. The clinical features, pathobiology, and epidemiology of influenza infections in pigs. In Animal Influenza; Wiley: Hoboken, NJ, USA, 2016; pp. 435–451. [Google Scholar]
  9. Janke, B.H. Influenza A virus infections in swine: Pathogenesis and diagnosis. Vet. Pathol. 2014, 51, 410–426. [Google Scholar] [CrossRef] [PubMed]
  10. Ma, W.; Vincent, A.L.; Lager, K.M.; Janke, B.H.; Henry, S.C.; Rowland, R.R.R.; Hesse, R.A.; Richt, J.A. Identification and characterization of a highly virulent triple reassortant H1N1 swine influenza virus in the United States. Virus Genes 2010, 40, 28–36. [Google Scholar] [CrossRef]
  11. Jung, K.; Ha, Y.; Chae, C. Pathogenesis of swine influenza virus subtype H1N2 infection in pigs. J. Comp. Pathol. 2005, 132, 179–184. [Google Scholar] [CrossRef]
  12. Lipatov, A.S.; Kwon, Y.K.; Sarmento, L.V.; Lager, K.M.; Spackman, E.; Suarez, D.L.; Swayne, D.E. Domestic pigs have low susceptibility to H5N1 highly pathogenic avian influenza viruses. PLoS Pathog. 2008, 4, e1000102. [Google Scholar] [CrossRef]
  13. Weingartl, H.M.; Albrecht, R.A.; Lager, K.M.; Babiuk, S.; Marszal, P.; Neufeld, J.; Embury-Hyatt, C.; Lekcharoensuk, P.; Tumpey, T.M.; García-Sastre, A.; et al. Experimental infection of pigs with the human 1918 pandemic influenza virus. J. Virol. 2009, 83, 4287–4296. [Google Scholar] [CrossRef] [PubMed]
  14. Winkler, G.C.; Cheville, N.F. Ultrastructural morphometric investigation of early lesions in the pulmonary alveolar region of pigs during experimental swine influenza infection. Am. J. Pathol. 1986, 122, 541–552. [Google Scholar] [PubMed]
  15. Kuiken, T.; van den Brand, J.; van Riel, D.; Pantin-Jackwood, M.; Swayne, D.E. Comparative pathology of select agent influenza a virus infections. Vet. Pathol. 2010, 47, 893–914. [Google Scholar] [CrossRef] [PubMed]
  16. Jung, T.; Choi, C.; Chae, C. Localization of Swine Influenza Virus in Naturally Infected Pigs. Vet. Pathol. 2002, 39, 10–16. [Google Scholar] [CrossRef] [PubMed]
  17. Vincent, L.L.; Janke, B.H.; Paul, P.S.; Halbur, P.G. A monoclonal-antibody-based immunohistochemical method for the detection of swine influenza virus in formalin-fixed, paraffin-embedded tissues. J. Vet. Diagn. Investig. 1997, 9, 191–195. [Google Scholar] [CrossRef] [PubMed]
  18. Mancera Gracia, J.C.; Pearce, D.S.; Masic, A.; Balasch, M. Influenza A Virus in Swine: Epidemiology, Challenges and Vaccination Strategies. Front. Vet. Sci. 2020, 7, 647. [Google Scholar] [CrossRef] [PubMed]
  19. Van Reeth, K.; Gracia, J.C.M.; Trus, I.; Sys, L.; Claes, G.; Versnaeyen, H.; Cox, E.; Krammer, F.; Qiu, Y. Heterologous prime-boost vaccination with H3N2 influenza viruses of swine favors cross-clade antibody responses and protection. NPJ Vaccines 2017, 2, 1–10. [Google Scholar] [CrossRef] [PubMed]
  20. Gauger, P.C.; Vincent, A.L.; Loving, C.L.; Henningson, J.N.; Lager, K.M.; Janke, B.H.; Kehrli, M.E.; Roth, J.A. Kinetics of lung lesion development and pro-inflammatory cytokine response in pigs with vaccine-associated enhanced respiratory disease induced by challenge with pandemic (2009) A/H1N1 influenza virus. Vet. Pathol. 2012, 49, 900–912. [Google Scholar] [CrossRef]
  21. Gauger, P.C.; Vincent, A.L.; Loving, C.L.; Lager, K.M.; Janke, B.H.; Kehrli, M.E.; Roth, J.A. Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (δ-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus. Vaccine 2011, 29, 2712–2719. [Google Scholar] [CrossRef]
  22. Holzer, B.; Martini, V.; Edmans, M.; Tchilian, E. T and B Cell Immune Responses to Influenza Viruses in Pigs. Front. Immunol. 2019, 10, 98. [Google Scholar] [CrossRef]
  23. Souza, C.K.; Rajão, D.S.; Sandbulte, M.R.; Lopes, S.; Lewis, N.S.; Loving, C.L.; Gauger, P.C.; Vincent, A.L. The type of adjuvant in whole inactivated influenza a virus vaccines impacts vaccine-associated enhanced respiratory disease. Vaccine 2018, 36, 6103–6110. [Google Scholar] [CrossRef] [PubMed]
  24. Fingerhut, L.; Dolz, G.; de Buhr, N. What Is the Evolutionary Fingerprint in Neutrophil Granulocytes? Int. J. Mol. Sci. 2020, 21, 4523. [Google Scholar] [CrossRef] [PubMed]
  25. Brinkmann, V. Neutrophil Extracellular Traps Kill Bacteria. Science 2004, 303, 1532–1535. [Google Scholar] [CrossRef]
  26. de Buhr, N.; Reuner, F.; Neumann, A.; Stump-Guthier, C.; Tenenbaum, T.; Schroten, H.; Ishikawa, H.; Müller, K.; Beineke, A.; Hennig-Pauka, I.; et al. Neutrophil extracellular trap formation in the Streptococcus suis-infected cerebrospinal fluid compartment. Cell. Microbiol. 2017, 19, e12649. [Google Scholar] [CrossRef] [PubMed]
  27. de Buhr, N.; Bonilla, M.C.; Pfeiffer, J.; Akhdar, S.; Schwennen, C.; Kahl, B.C.; Waldmann, K.; Valentin-Weigand, P.; Hennig-Pauka, I.; von Köckritz-Blickwede, M. Degraded neutrophil extracellular traps promote the growth of Actinobacillus pleuropneumoniae. Cell Death Dis. 2019, 10, 657. [Google Scholar] [CrossRef] [PubMed]
  28. Hennig-Pauka, I.; Imker, R.; Mayer, L.; Brügmann, M.; Werckenthin, C.; Weber, H.; Menrath, A.; de Buhr, N. From Stable to Lab—Investigating Key Factors for Sudden Deaths Caused by Streptococcus suis. Pathogens 2019, 8, 249. [Google Scholar] [CrossRef]
  29. Lassnig, S.; Hennig-Pauka, I.; Bonilla, M.C.; Mörgelin, M.; Imker, R.; von Köckritz-Blickwede, M.; de Buhr, N. Impact of bronchoalveolar lavage from influenza A virus diseased pigs on neutrophil functions and growth of co-infecting pathogenic bacteria. Front. Immunol. 2024, 15, 1325269. [Google Scholar] [CrossRef]
  30. Narasaraju, T.; Yang, E.; Samy, R.P.; Ng, H.H.; Poh, W.P.; Liew, A.-A.; Phoon, M.C.; van Rooijen, N.; Chow, V.T. Excessive Neutrophils and Neutrophil Extracellular Traps Contribute to Acute Lung Injury of Influenza Pneumonitis. Am. J. Pathol. 2011, 179, 199–210. [Google Scholar] [CrossRef]
  31. Goldmann, O.; Medina, E. The expanding world of extracellular traps: Not only neutrophils but much more. Front. Immunol. 2012, 3, 420. [Google Scholar] [CrossRef]
  32. Bigay, J.; Le Grand, R.; Martinon, F.; Maisonnasse, P. Vaccine-associated enhanced disease in humans and animal models: Lessons and challenges for vaccine development. Front. Microbiol. 2022, 13, 932408. [Google Scholar] [CrossRef]
  33. Tabynov, K.; Sansyzbay, A.; Tulemissova, Z.; Tabynov, K.; Dhakal, S.; Samoltyrova, A.; Renukaradhya, G.J.; Mambetaliyev, M. Inactivated porcine reproductive and respiratory syndrome virus vaccine adjuvanted with MontanideTM Gel 01 ST elicits virus-specific cross-protective inter-genotypic response in piglets. Vet. Microbiol. 2016, 192, 81–89. [Google Scholar] [CrossRef] [PubMed]
  34. Goodell, C.K.; Zhang, J.; Strait, E.; Harmon, K.; Patnayak, D.; Otterson, T.; Culhane, M.; Christopher-Hennings, J.; Clement, T.; Leslie-Steen, P.; et al. Ring test evaluation of the detection of influenza A virus in swine oral fluids by real-time reverse-transcription polymerase chain reaction and virus isolation. Can. J. Vet. Res. 2016, 80, 12–20. [Google Scholar] [PubMed]
  35. Wehrend, A.; Hetzel, U.; Huchzermeyer, S.; Klein, C.; Bostedt, H. Sirius red is able to selectively stain eosinophil granulocytes in bovine, ovine and equine cervical tissue. Anat. Histol. Embryol. 2004, 33, 180–182. [Google Scholar] [CrossRef] [PubMed]
  36. de Buhr, N.; Martens, A.; Meurer, M.; Bonilla, M.C.; Söbbeler, F.; Twele, L.; Neudeck, S.; Wendt, M.; Beineke, A.; Kästner, S.; et al. In vivo oxygen measurement in cerebrospinal fluid of pigs to determine physiologic and pathophysiologic oxygen values during CNS infections. BMC Neurosci. 2021, 22, 45. [Google Scholar] [CrossRef] [PubMed]
  37. Gauger, P.C.; Loving, C.L.; Khurana, S.; Lorusso, A.; Perez, D.R.; Kehrli, M.E.; Roth, J.A.; Golding, H.; Vincent, A.L. Live attenuated influenza A virus vaccine protects against A(H1N1)pdm09 heterologous challenge without vaccine associated enhanced respiratory disease. Virology 2014, 471–473, 93–104. [Google Scholar] [CrossRef] [PubMed]
  38. Reineking, W.; Schauerte, I.E.; Junginger, J.; Hewicker-Trautwein, M. Sox9, Hopx, and survivin and tuft cell marker DCLK1 expression in normal canine intestine and in intestinal adenoma and adenocarcinoma. Vet. Pathol. 2022, 59, 415–426. [Google Scholar] [CrossRef]
  39. Becker, K.; Beythien, G.; de Buhr, N.; Stanelle-Bertram, S.; Tuku, B.; Kouassi, N.M.; Beck, S.; Zickler, M.; Allnoch, L.; Gabriel, G.; et al. Vasculitis and Neutrophil Extracellular Traps in Lungs of Golden Syrian Hamsters With SARS-CoV-2. Front. Immunol. 2021, 12, 1. [Google Scholar]
  40. Madec, F.; Kaiser, C.; Gourreau, J.M.; Martinat-Botte, F. Pathologic consequences of a severe influenza outbreak (swine virus A/H1N1) under natural conditions in the non-immune sow at the beginning of pregnancy. Comp. Immunol. Microbiol. Infect. Dis. 1989, 12, 17–27. [Google Scholar] [CrossRef]
  41. Vincent, A.L.; Perez, D.R.; Rajao, D.; Anderson, T.K.; Abente, E.J.; Walia, R.R.; Lewis, N.S. Influenza A virus vaccines for swine. Vet. Microbiol. 2017, 206, 35–44. [Google Scholar] [CrossRef]
  42. Rothenberg, M.E.; Hogan, S.P. The eosinophil. Annu. Rev. Immunol. 2006, 24, 147–174. [Google Scholar] [CrossRef]
  43. Kanda, A.; Yun, Y.; Van Bui, D.; Nguyen, L.M.; Kobayashi, Y.; Suzuki, K.; Mitani, A.; Sawada, S.; Hamada, S.; Asako, M.; et al. The multiple functions and subpopulations of eosinophils in tissues under steady-state and pathological conditions. Allergol. Int. 2021, 70, 9–18. [Google Scholar] [CrossRef] [PubMed]
  44. Mesnil, C.; Raulier, S.; Paulissen, G.; Xiao, X.; Birrell, M.A.; Pirottin, D.; Janss, T.; Starkl, P.; Ramery, E.; Henket, M.; et al. Lung-resident eosinophils represent a distinct regulatory eosinophil subset. J. Clin. Investig. 2016, 126, 3279–3295. [Google Scholar] [CrossRef] [PubMed]
  45. Weller, P.F.; Spencer, L.A. Functions of tissue-resident eosinophils. Nat. Rev. Immunol. 2017, 17, 746–760. [Google Scholar] [CrossRef] [PubMed]
  46. Kanda, A.; Yasutaka, Y.; Van Bui, D.; Suzuki, K.; Sawada, S.; Kobayashi, Y.; Asako, M.; Iwai, H. Multiple Biological Aspects of Eosinophils in Host Defense, Eosinophil-Associated Diseases, Immunoregulation, and Homeostasis: Is Their Role Beneficial, Detrimental, Regulator, or Bystander? Biol. Pharm. Bull. 2020, 43, 20–30. [Google Scholar] [CrossRef] [PubMed]
  47. Fornhem, C.; Peterson, C.G.; Alving, K. Isolation and characterization of porcine cationic eosinophil granule proteins. Int. Arch. Allergy Immunol. 1996, 110, 132–142. [Google Scholar] [CrossRef] [PubMed]
  48. Fornhem, C.; Kumlin, M.; Lundberg, J.M.; Alving, K. Allergen-induced late-phase airways obstruction in the pig: Mediator release and eosinophil recruitment. Eur. Respir. J. 1995, 8, 1100–1109. [Google Scholar] [CrossRef] [PubMed]
  49. Wymore Brand, M.; Anderson, T.K.; Kitikoon, P.; Brian Kimble, J.; Otis, N.; Gauger, P.C.; Souza, C.K.; Kaplan, B.; Mogler, M.; Strait, E.; et al. Bivalent hemagglutinin and neuraminidase influenza replicon particle vaccines protect pigs against influenza a virus without causing vaccine associated enhanced respiratory disease. Vaccine 2022, 40, 5569–5578. [Google Scholar] [CrossRef] [PubMed]
  50. Graaf-Rau, A.; Hennig, C.; Lillie-Jaschniski, K.; Koechling, M.; Stadler, J.; Boehmer, J.; Ripp, U.; Pohlmann, A.; Schwarz, B.-A.; Beer, M.; et al. Emergence of swine influenza A virus, porcine respirovirus 1 and swine orthopneumovirus in porcine respiratory disease in Germany. Emerg. Microbes Infect. 2023, 12, 2239938. [Google Scholar] [CrossRef] [PubMed]
  51. Castelán-Vega, J.A.; Magaña-Hernández, A.; Jiménez-Alberto, A.; Ribas-Aparicio, R.M. The hemagglutinin of the influenza A(H1N1)pdm09 is mutating towards stability. Adv. Appl. Bioinform. Chem. 2014, 7, 37–44. [Google Scholar]
  52. Ebenig, A.; Muraleedharan, S.; Kazmierski, J.; Todt, D.; Auste, A.; Anzaghe, M.; Gömer, A.; Postmus, D.; Gogesch, P.; Niles, M.; et al. Vaccine-associated enhanced respiratory pathology in COVID-19 hamsters after TH2-biased immunization. Cell Rep. 2022, 40, 111214. [Google Scholar] [CrossRef]
  53. Graham, B.S. Rapid COVID-19 vaccine development. Science 2020, 368, 945–946. [Google Scholar] [CrossRef] [PubMed]
  54. Ruckwardt, T.J.; Morabito, K.M.; Graham, B.S. Immunological Lessons from Respiratory Syncytial Virus Vaccine Development. Immunity 2019, 51, 429–442. [Google Scholar] [CrossRef] [PubMed]
  55. Waris, M.E.; Tsou, C.; Erdman, D.D.; Zaki, S.R.; Anderson, L.J. Respiratory synctial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern. J. Virol. 1996, 70, 2852–2860. [Google Scholar] [CrossRef] [PubMed]
  56. Gartlan, C.; Tipton, T.; Salguero, F.J.; Sattentau, Q.; Gorringe, A.; Carroll, M.W. Vaccine-Associated Enhanced Disease and Pathogenic Human Coronaviruses. Front. Immunol. 2022, 13, 882972. [Google Scholar] [CrossRef] [PubMed]
  57. Larrañaga, J.M.; Marcos, P.J.; Pombo, F.; Otero-González, I. Acute eosinophilic pneumonia as a complication of influenza A (H1N1) pulmonary infection. Sarcoidosis Vasc. Diffus. Lung Dis. 2016, 33, 95–97. [Google Scholar]
  58. Terai, M.; Honda, T.; Yamamoto, S.; Yoshida, M.; Tsuchiya, N.; Moriyama, Y.; Matsui, T.; Tokutake, S.; Suzuki, E.; Shirato, Y.; et al. Early induction of interleukin-5 and peripheral eosinophilia in acute pneumonia in Japanese children infected by pandemic 2009 influenza A in the Tokyo area. Microbiol. Immunol. 2011, 55, 341–346. [Google Scholar] [CrossRef] [PubMed]
  59. Jeon, E.J.; Kim, K.H.; Min, K.H. Acute eosinophilic pneumonia associated with 2009 influenza A (H1N1). Thorax 2010, 65, 268–270. [Google Scholar] [CrossRef] [PubMed]
  60. Chang, L.A.; Choi, A.; Rathnasinghe, R.; Warang, P.; Noureddine, M.; Jangra, S.; Chen, Y.; De Geest, B.G.; Schotsaert, M. Influenza breakthrough infection in vaccinated mice is characterized by non-pathological lung eosinophilia. Front. Immunol. 2023, 14, 1217181. [Google Scholar] [CrossRef] [PubMed]
  61. Choi, A.; Ibañez, L.I.; Strohmeier, S.; Krammer, F.; García-Sastre, A.; Schotsaert, M. Non-sterilizing, Infection-Permissive Vaccination With Inactivated Influenza Virus Vaccine Reshapes Subsequent Virus Infection-Induced Protective Heterosubtypic Immunity From Cellular to Humoral Cross-Reactive Immune Responses. Front. Immunol. 2020, 11, 1166. [Google Scholar] [CrossRef]
  62. Rajão, D.S.; Chen, H.; Perez, D.R.; Sandbulte, M.R.; Gauger, P.C.; Loving, C.L.; Shanks, G.D.; Vincent, A. Vaccine-associated enhanced respiratory disease is influenced by haemagglutinin and neuraminidase in whole inactivated influenza virus vaccines. J. Gen. Virol. 2016, 97, 1489–1499. [Google Scholar] [CrossRef]
  63. de Souza, C.N.; Breda, L.C.D.; Khan, M.A.; de Almeida, S.R.; Câmara, N.O.S.; Sweezey, N.; Palaniyar, N. Alkaline pH promotes NADPH oxidase-independent neutrophil extracellular trap formation: A matter of mitochondrial reactive oxygen species generation and citrullination and cleavage of histone. Front. Immunol. 2018, 8, 1849. [Google Scholar] [CrossRef] [PubMed]
  64. Macchia, I.; La Sorsa, V.; Urbani, F.; Moretti, S.; Antonucci, C.; Afferni, C.; Schiavoni, G. Eosinophils as potential biomarkers in respiratory viral infections. Front. Immunol. 2023, 14, 1170035. [Google Scholar] [CrossRef] [PubMed]
  65. Samarasinghe, A.E.; Melo, R.C.N.; Duan, S.; LeMessurier, K.S.; Liedmann, S.; Surman, S.L.; Lee, J.J.; Hurwitz, J.L.; Thomas, P.G.; McCullers, J.A. Eosinophils Promote Antiviral Immunity in Mice Infected with Influenza A Virus. J. Immunol. 2017, 198, 3214–3226. [Google Scholar] [CrossRef]
  66. Knudson, C.J.; Hartwig, S.M.; Meyerholz, D.K.; Varga, S.M. RSV vaccine-enhanced disease is orchestrated by the combined actions of distinct CD4 T cell subsets. PLoS Pathog. 2015, 11, e1004757. [Google Scholar] [CrossRef] [PubMed]
  67. Narayana Moorthy, A.; Narasaraju, T.; Rai, P.; Perumalsamy, R.; Tan, K.B.; Wang, S.; Engelward, B.; Chow, V.T.K. In vivo and in vitro studies on the roles of neutrophil extracellular traps during secondary pneumococcal pneumonia after primary pulmonary influenza infection. Front. Immunol. 2013, 4, 56. [Google Scholar] [CrossRef] [PubMed]
  68. Tripathi, S.; Verma, A.; Kim, E.-J.; White, M.R.; Hartshorn, K.L. LL-37 modulates human neutrophil responses to influenza A virus. J. Leukoc. Biol. 2014, 96, 931–938. [Google Scholar] [CrossRef] [PubMed]
  69. Chan, L.L.Y.; Nicholls, J.M.; Peiris, J.S.M.; Lau, Y.L.; Chan, M.C.W.; Chan, R.W.Y. Host DNA released by NETosis in neutrophils exposed to seasonal H1N1 and highly pathogenic H5N1 influenza viruses. Respir. Res. 2020, 21, 160. [Google Scholar] [CrossRef] [PubMed]
  70. Saffarzadeh, M.; Juenemann, C.; Queisser, M.A.; Lochnit, G.; Barreto, G.; Galuska, S.P.; Lohmeyer, J.; Preissner, K.T. Neutrophil Extracellular Traps Directly Induce Epithelial and Endothelial Cell Death: A Predominant Role of Histones. PLoS ONE 2012, 7, e32366. [Google Scholar] [CrossRef] [PubMed]
  71. Abrams, S.T.; Zhang, N.; Manson, J.; Liu, T.; Dart, C.; Baluwa, F.; Wang, S.S.; Brohi, K.; Kipar, A.; Yu, W.; et al. Circulating histones are mediators of trauma-associated lung injury. Am. J. Respir. Crit. Care Med. 2013, 187, 160–169. [Google Scholar] [CrossRef]
  72. Xu, J.; Zhang, X.; Pelayo, R.; Monestier, M.; Ammollo, C.T.; Semeraro, F.; Taylor, F.B.; Esmon, N.L.; Lupu, F.; Esmon, C.T. Extracellular histones are major mediators of death in sepsis. Nat. Med. 2009, 15, 1318–1321. [Google Scholar] [CrossRef]
  73. Twaddell, S.H.; Baines, K.J.; Grainge, C.; Gibson, P.G. The Emerging Role of Neutrophil Extracellular Traps in Respiratory Disease. Chest 2019, 156, 774–782. [Google Scholar] [CrossRef] [PubMed]
  74. Yousefi, S.; Gold, J.A.; Andina, N.; Lee, J.J.; Kelly, A.M.; Kozlowski, E.; Schmid, I.; Straumann, A.; Reichenbach, J.; Gleich, G.J.; et al. Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat. Med. 2008, 14, 949–953. [Google Scholar] [CrossRef] [PubMed]
  75. Gevaert, E.; Zhang, N.; Krysko, O.; Lan, F.; Holtappels, G.; De Ruyck, N.; Nauwynck, H.; Yousefi, S.; Simon, H.-U.; Bachert, C. Extracellular eosinophilic traps in association with Staphylococcus aureus at the site of epithelial barrier defects in patients with severe airway inflammation. J. Allergy Clin. Immunol. 2017, 139, 1849–1860.e6. [Google Scholar] [CrossRef] [PubMed]
  76. Omokawa, A.; Ueki, S.; Kikuchi, Y.; Takeda, M.; Asano, M.; Sato, K.; Sano, M.; Ito, H.; Hirokawa, M. Mucus plugging in allergic bronchopulmonary aspergillosis: Implication of the eosinophil DNA traps. Allergol. Int. 2018, 67, 280–282. [Google Scholar] [CrossRef] [PubMed]
  77. de Buhr, N.; Bonilla, M.C.; Jimenez-Soto, M.; von Köckritz-Blickwede, M.; Dolz, G. Extracellular Trap Formation in Response to Trypanosoma cruzi Infection in Granulocytes Isolated From Dogs and Common Opossums, Natural Reservoir Hosts. Front. Microbiol. 2018, 9, 966. [Google Scholar] [CrossRef] [PubMed]
  78. Silveira, J.S.; Antunes, G.L.; Gassen, R.B.; Breda, R.V.; Stein, R.T.; Pitrez, P.M.; da Cunha, A.A. Respiratory syncytial virus increases eosinophil extracellular traps in a murine model of asthma. Asia Pac. Allergy 2019, 9, e32. [Google Scholar] [CrossRef]
  79. Yoshida, M.; Miyahara, Y.; Orimo, K.; Kono, N.; Narita, M.; Ohya, Y.; Matsumoto, K.; Nakagawa, S.; Ueki, S.; Morita, H.; et al. Eosinophil Extracellular Traps in the Casts of Plastic Bronchitis Associated With Influenza Virus Infection. Chest 2021, 160, 854–857. [Google Scholar] [CrossRef]
Viruses 16 00955 g001
Figure 1. Morphological findings in IAV-infected sows. (A,C): Accentuated around bronchi and larger vessels, there was a marked infiltration of neutrophilic and eosinophilic granulocytes as well as lower numbers of macrophages and lymphocytes (*). Multifocally, pronounced edema was present. Hematoxylin and eosin. Bar: 500 μm. (B,D): The presence of eosinophils was confirmed by the Sirius red stainability of numerous granulocytes (*). Sirius red. Bar: 500 μm.
Figure 1. Morphological findings in IAV-infected sows. (A,C): Accentuated around bronchi and larger vessels, there was a marked infiltration of neutrophilic and eosinophilic granulocytes as well as lower numbers of macrophages and lymphocytes (*). Multifocally, pronounced edema was present. Hematoxylin and eosin. Bar: 500 μm. (B,D): The presence of eosinophils was confirmed by the Sirius red stainability of numerous granulocytes (*). Sirius red. Bar: 500 μm.
Viruses 16 00955 g001
Viruses 16 00955 g002
Figure 2. Detection of NETs in lung tissue. (A) Representative pictures of immunofluorescence microscopy are shown (blue = DNA (Hoechst), green = DNA-histone-1-complexes, red = MPO). The right image is a magnification from the left image, and the arrowhead marks a NET fiber. The scale bar in all images represents 50 µm. (B) Stained lung slices of three to six animals per group were analyzed from two technical runs per animal. Images were analyzed using ImageJ (version 1.5.4) software to determine the percentage of mean fluorescence of the green (DNA-histone-1-complex) and magenta (MPO) signals based on the blue signal (nuclei). The means from the technical runs were calculated and used for statistics. Per animal, 10 immunofluorescence microscopy images were analyzed in each technical run (control n = 6, IAV n = 3, VAERD n = 6 animals). A high intensity of MPO signals was detectable in the lungs of VAERD sows. Data were analyzed with ordinary one-way ANOVA followed by Dunnett’s multiple comparisons test and are presented with mean ± SD (* p ≤ 0.05, ** p ≤ 0.01).
Figure 2. Detection of NETs in lung tissue. (A) Representative pictures of immunofluorescence microscopy are shown (blue = DNA (Hoechst), green = DNA-histone-1-complexes, red = MPO). The right image is a magnification from the left image, and the arrowhead marks a NET fiber. The scale bar in all images represents 50 µm. (B) Stained lung slices of three to six animals per group were analyzed from two technical runs per animal. Images were analyzed using ImageJ (version 1.5.4) software to determine the percentage of mean fluorescence of the green (DNA-histone-1-complex) and magenta (MPO) signals based on the blue signal (nuclei). The means from the technical runs were calculated and used for statistics. Per animal, 10 immunofluorescence microscopy images were analyzed in each technical run (control n = 6, IAV n = 3, VAERD n = 6 animals). A high intensity of MPO signals was detectable in the lungs of VAERD sows. Data were analyzed with ordinary one-way ANOVA followed by Dunnett’s multiple comparisons test and are presented with mean ± SD (* p ≤ 0.05, ** p ≤ 0.01).
Viruses 16 00955 g002
Viruses 16 00955 g003
Figure 3. Comparison of eosinophilic count in the different study groups. (A,E): In IAV-infected sows, numerous eosinophils (arrows) are present within the mucosa and submucosal tissues. Neutrophils are occasionally present within the mucosa (arrowhead). No Sirius red stain was observed in neutrophils ((E); arrowhead). (B,F): The IAV-infected younger pigs have scattered eosinophils (arrows) within the alveolar septa. (C,G): Low numbers of eosinophils (arrows) are also present within the submucosal tissue and alveolar septa of the APP-infected group. The majority of intraluminal cells were confirmed as neutrophils (arrowheads) by their lack of Sirius red staining (G). (D,H): Single eosinophils (arrows) were present in the alveolar septa of healthy control pigs. ((A–D): Hematoxylin-eosin; (E–H): Sirius red stain). Bars: 100 μm.
Figure 3. Comparison of eosinophilic count in the different study groups. (A,E): In IAV-infected sows, numerous eosinophils (arrows) are present within the mucosa and submucosal tissues. Neutrophils are occasionally present within the mucosa (arrowhead). No Sirius red stain was observed in neutrophils ((E); arrowhead). (B,F): The IAV-infected younger pigs have scattered eosinophils (arrows) within the alveolar septa. (C,G): Low numbers of eosinophils (arrows) are also present within the submucosal tissue and alveolar septa of the APP-infected group. The majority of intraluminal cells were confirmed as neutrophils (arrowheads) by their lack of Sirius red staining (G). (D,H): Single eosinophils (arrows) were present in the alveolar septa of healthy control pigs. ((A–D): Hematoxylin-eosin; (E–H): Sirius red stain). Bars: 100 μm.
Viruses 16 00955 g003
Viruses 16 00955 g004
Figure 4. Quantification of Sirius red-positive cells. Increased numbers of Sirius red-positive cells were detected within the IAV-infected sows compared to younger IAV-infected pigs as well as APP-infected pigs and healthy controls. Statistical analysis showed significant differences between the IAV-infected sows compared to healthy controls and APP pigs, but not to the younger IAV-infected group. Min-to-max Box-and-Whisker plot. Kruskal–Wallis test with subsequent Dunn’s test for multiple comparisons. *, p ≤ 0.05; **, p ≤ 0.01; SR, Sirius red; +, mean count of cells.
Figure 4. Quantification of Sirius red-positive cells. Increased numbers of Sirius red-positive cells were detected within the IAV-infected sows compared to younger IAV-infected pigs as well as APP-infected pigs and healthy controls. Statistical analysis showed significant differences between the IAV-infected sows compared to healthy controls and APP pigs, but not to the younger IAV-infected group. Min-to-max Box-and-Whisker plot. Kruskal–Wallis test with subsequent Dunn’s test for multiple comparisons. *, p ≤ 0.05; **, p ≤ 0.01; SR, Sirius red; +, mean count of cells.
Viruses 16 00955 g004
Table 1. Anamnestic data of pigs included in this study.
Table 1. Anamnestic data of pigs included in this study.
GroupFarmAnimal no. Age Group/
Stage of Production *		SexWeight [kg]Origin
IAV sowsA1giltFemale121Bakum
A2giltFemale136Bakum
A3giltFemale134Bakum
B1sowFemale289Bakum
B2sowFemale239Bakum
B3sowFemale231Bakum
IAV pigsC1Nursery pigMale neutered6.3Bakum
D1Suckling pigletMale neutered5.6Bakum
E1Suckling pigletMale neutered3.1Bakum
F1Nursery pigMale neutered20.2Pathology
F2Fattening pigMale neutered38.9Pathology
G1Fattening pigMale25Pathology
APPH1fattening pigFemale92Pathology
H2fattening pigMale neutered52Pathology
H3fattening pigMale neutered70Pathology
H4fattening pigFemale92Pathology
I1fattening pigFemale34.6Pathology
J1fattening pigMale neutered32Pathology
Healthy controlsRIZ1Nursery pigFemale13Pathology
RIZ2Nursery pigFemale14Pathology
RIZ3Nursery pigMale neutered14Pathology
RIZ4Nursery pigFemale16Pathology
RIZ5Nursery pigMale neutered16Pathology
RIZ6Nursery pigFemale15Pathology
* Suckling piglet: <6 kg and from farrowing pen, nursery pig: ≤25 kg and from nursery unit; fattening pig: 26–100 kg and from fattening unit; gilt: <150 kg, sow >200 kg.
Table 2. Primary antibodies used for immunohistochemistry.
Table 2. Primary antibodies used for immunohistochemistry.
AntigenHostClonalityCompanyCat. No.PretreatmentDilution
human CD3rabbitpolyclonalDakoA0452HIER 11:200
human CD20rabbitpolyclonalInvitrogenPA5-16701HIER 11:300
human eosinophilic peroxidaserabbitpolyclonalAbcamab238506HIER 21:2000
human Iba-1rabbitpolyclonalWako019-19741HIER 11:500
Influenza A nucleoproteinmousemonoclonal; clone HB65KerafastFCG013Proteinase K1:200
HIER: heat-induced epitope retrieval; 1 citrate buffer, pH6, microwave, 20 min; 2 Target Unmasking Fluid® (PanPath, Budel, The Netherlands; Cat. SSP-0025-TUF3), steamer, 95 °C, 15 min.
Table 3. Diagnostic findings in six sows with VAERD.
Table 3. Diagnostic findings in six sows with VAERD.
Animal NumberIAV detected in Lung TissueAdditional Findings in Other Organs
A1+H1avN1-
A2+Subtyping not successfulLymphnode: PCV2 negative
A3+Lymphnode: PCV2 negative
Meninges: Streptococcus suis
B1+Pleura/Peritoneum: β-haemolytic streptococci
B2+Meninges: Pasteurella multocida
B3+H1avN2-
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Reineking, W.; Hennig-Pauka, I.; Schröder, L.; Höner, U.; Schreiber, E.; Geiping, L.; Lassnig, S.; Bonilla, M.C.; Hewicker-Trautwein, M.; de Buhr, N. Spontaneous Lethal Outbreak of Influenza A Virus Infection in Vaccinated Sows on Two Farms Suggesting the Occurrence of Vaccine-Associated Enhanced Respiratory Disease with Eosinophilic Lung Pathology. Viruses 2024, 16, 955. https://doi.org/10.3390/v16060955

AMA Style

Reineking W, Hennig-Pauka I, Schröder L, Höner U, Schreiber E, Geiping L, Lassnig S, Bonilla MC, Hewicker-Trautwein M, de Buhr N. Spontaneous Lethal Outbreak of Influenza A Virus Infection in Vaccinated Sows on Two Farms Suggesting the Occurrence of Vaccine-Associated Enhanced Respiratory Disease with Eosinophilic Lung Pathology. Viruses. 2024; 16(6):955. https://doi.org/10.3390/v16060955

Chicago/Turabian Style

Reineking, Wencke, Isabel Hennig-Pauka, Ludger Schröder, Ulf Höner, Elena Schreiber, Lukas Geiping, Simon Lassnig, Marta C. Bonilla, Marion Hewicker-Trautwein, and Nicole de Buhr. 2024. "Spontaneous Lethal Outbreak of Influenza A Virus Infection in Vaccinated Sows on Two Farms Suggesting the Occurrence of Vaccine-Associated Enhanced Respiratory Disease with Eosinophilic Lung Pathology" Viruses 16, no. 6: 955. https://doi.org/10.3390/v16060955

APA Style

Reineking, W., Hennig-Pauka, I., Schröder, L., Höner, U., Schreiber, E., Geiping, L., Lassnig, S., Bonilla, M. C., Hewicker-Trautwein, M., & de Buhr, N. (2024). Spontaneous Lethal Outbreak of Influenza A Virus Infection in Vaccinated Sows on Two Farms Suggesting the Occurrence of Vaccine-Associated Enhanced Respiratory Disease with Eosinophilic Lung Pathology. Viruses, 16(6), 955. https://doi.org/10.3390/v16060955

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop